EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank

Charikleia Chatzigeorgiou iD, John C Taylor iD, Faye Elliott iD, Eoin P O'Sullivan iD, Ann W Morgan iD, Jennifer H Barrett iD, Sarah L Mackie iD

Rheumatology Advances in Practice · 26.08.2023 · 7 (3)

DOI: 10.1093/rap/rkad095 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Rheumatology Advances in Practice, online erschienen am 02.11.2023. Verfasst von Charikleia Chatzigeorgiou und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Leeds, Leeds, UK. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, University of Leeds, NIHR Leeds Biomedical Research Centre and NIHR Leeds Medicines.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim was to determine prevalent co-morbidities in cases with PMR or GCA compared with matched controls.

Methods

This was a nested, cross-sectional case–control study within the UK Biobank, which recruited participants aged 40–69 years. Case status was defined as self-reported prior diagnosis of PMR or GCA. Ten controls per case were matched for age, sex, ethnicity and assessment centre. Associations with selected self-reported co-morbidities were studied using conditional logistic regression.

Results

Of PMR (n = 1036) or GCA (n = 102) cases, 72% were female, 98% White, and 58% reported current use of glucocorticoids. Mean age was 63 years. At the time of the assessment visit, compared with controls, PMR/GCA cases were more likely to report poor general health and at least several days of low mood in the past 2 weeks. PMR was associated with hypothyroidism [odds ratio (OR) = 1.34; 95% CI = 1.07, 1.67] and ever-use of HRT (OR = 1.26; 95% CI = 1.07, 1.47). Regarding common co-morbidities, PMR and GCA were both associated with hypertension (PMR: OR = 1.21; 95% CI = 1.06, 1.39; GCA: OR = 1.86; 95% CI = 1.23, 2.81) and cataract (PMR: OR = 1.51; 95% CI = 1.19, 1.93; GCA: OR = 3.84; 95% CI = 2.23, 6.60). Additionally, GCA was associated with depression (OR = 3.05; 95% CI = 1.59, 5.85). Neither condition was associated with diabetes.

Conclusion

Participants with a history of PMR/GCA, including those not currently taking glucocorticoids, rated their health as poorer than matched controls. Some previously described disease associations (hypothyroidism and early menopause) were replicated. Hypertension and cataract, both of which can be exacerbated by long-term glucocorticoid therapy, were over-represented in both diseases, particularly GCA.

Schlagwörter

Stichwörter der Autor:innen

UK Biobankco-morbiditiesepidemiologygiant cell arteritispolymyalgia rheumatica

Autor:innen und Institutionen

  • School of Medicine, University of Leeds, Leeds, UK.
  • NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Leeds Institute of Data Analytics, University of Leeds, Leeds, UK.
  • Department of Ophthalmology, King's College Hospital NHS Foundation Trust, London, UK.
  • NIHR Leeds Medicines and In Vitro Diagnostics Co-operative, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

ORCID-Profile: Charikleia Chatzigeorgiou, John C Taylor, Faye Elliott, Eoin P O'Sullivan, Ann W Morgan, Jennifer H Barrett, Sarah L Mackie

Förderung

  • Medical Research Council
  • University of Leeds
  • NIHR Leeds Biomedical Research Centre and NIHR Leeds Medicines
  • In Vitro Diagnostics Co-operative

Zitieren

APA

Chatzigeorgiou, C., Taylor, J. C., Elliott, F., O'Sullivan, E. P., Morgan, A. W., Barrett, J. H., & Mackie, S. L. (2023). Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank. Rheumatology Advances in Practice, 7(3). https://doi.org/10.1093/rap/rkad095

Vancouver

Chatzigeorgiou C, Taylor JC, Elliott F, O'Sullivan EP, Morgan AW, Barrett JH, et al. Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank. Rheumatology Advances in Practice. 2023;7(3). doi:10.1093/rap/rkad095

BibTeX
@article{Chatzigeorgiou2023,
  author = {Chatzigeorgiou, Charikleia and Taylor, John C and Elliott, Faye and O'Sullivan, Eoin P and Morgan, Ann W and Barrett, Jennifer H and Mackie, Sarah L},
  title = {Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank},
  journal = {Rheumatology Advances in Practice},
  year = {2023},
  volume = {7},
  number = {3},
  doi = {10.1093/rap/rkad095}
}
Kostenlos starten →